Abstract:Ann-Kathrin Rahm, 1– 3 Dominik Gramlich, 1– 3 Teresa Wieder, 1, 2 Mara Elena Müller, 1– 3 Axel Schoeffel, 1, 2 Fadwa A El Tahry, 1 Patrick Most, 1, 2 Tanja Heimberger, 1, 3 Steffi Sandke, 1, 3 Tanja Weis, 1, 3 Nina D Ullrich, 4 Thomas Korff, 4, 5 Patrick Lugenbiel, 1– 3 Hugo A Katus, 1– 3 Dierk Thomas 1– 3 1 Department of Cardiology, Medical University Hospital Heidelberg, Heidelberg, 69120, Germany; 2 HCR (Heidelberg Center for Heart Rhythm Disorders), University Hospital Heidelberg, Heidelberg, 69120, Germany; 3 DZHK (German Centre for Cardiovascular Research), Partner Site Heidelberg/Mannheim, University of Heidelberg, Heidelberg, 69120, Germany; 4 Institute of Physiology and Pathophysiology, Department of Cardiovascular Physiology, Heidelberg University, Heidelberg, 69120, Germany; 5 European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, 68167, Germany Correspondence: Dierk Thomas Department of Cardiology, University of Heidelberg, Im Neuenheimer Feld 410, Heidelberg, 69120, Germany Tel +49 6221 568855 Fax +49 6221 565514 Email Aim: Effective antiarrhythmic treatment of atrial fibrillation (AF) constitutes a major challenge, in particular, when concomitant heart failure (HF) is present. HF-associated atrial arrhythmogenesis is distinctly characterized by prolonged atrial refractoriness. Small-conductance, calcium-activated K + (K Ca , SK, KCNN ) channels contribute to cardiac action potential repolarization and are implicated in AF susceptibility and therapy. The mechanistic impact of AF/HF-related triggers on atrial K Ca channels is not known. We hypothesized that tachycardia, stretch, β-adrenergic stimulation, and hypoxia differentially determine K Ca 2.1– 2.3 channel remodeling in atrial cells. Methods: KCNN1-3 transcript levels were assessed in AF/HF patients and in a pig model of atrial tachypacing-induced AF with reduced left ventricular function. HL-1 atrial myocytes were subjected to proarrhythmic triggers to investigate the effects on Kcnn mRNA and K Ca channel protein. Results: Atrial KCNN1-3 expression was reduced in AF/HF patients. KCNN2 and KCNN3 suppression was recapitulated in the corresponding pig model. In contrast to human AF, KCNN1 remained unchanged in pigs. Channel- and stressor-specific remodeling was revealed in vitro. Lower expression levels of KCNN1 /K Ca 2.1 were linked to stretch and β-adrenergic stimulation. Furthermore, KCNN3 /K Ca 2.3 expression was suppressed upon tachypacing and hypoxia. Finally, KCNN2 /K Ca 2.2 abundance was specifically enhanced by hypoxia. Conclusion: Reduction of K Ca 2.1– 2.3 channel expression might contribute to the action potential prolongation in AF complicated by HF. Subtype-specific K Ca 2 channel remodeling induced by tachypacing, stretch, β-adrenergic stimulation, or hypoxia is expected to differentially determine atrial remodeling, depending on patient-specific activation of each triggering factor. Stressor-dependent K Ca 2 regulation in atrial myocytes provides a starting point for mechanism-based antiarrhythmic therapy. Keywords: atrial fibrillation, calcium, K Ca channel, KCNN , remodeling, SK channel Atrial fibrillation (AF) is the most common cardiac arrhythmia and accounts for significant morbidity and mortality. Effective antiarrhythmic treatment of AF still exhibits suboptimal effectiveness due to patient-specific characteristics that individually determine atrial arrhythmogenesis. Among these, heart failure (HF) worsens the prognosis of AF patients and poses a particular therapeutic challenge that is mechanistically attributed to a distinct atrial substrate. Atrial action potential duration (APD) and effective refractory period (AERP) are prolonged in AF complicated by HF in humans and in animal models, 1 requiring tailored therapeutic approaches. During AF and HF, multiple mechanisms including tachycardia, stretch, β-adrenergic stimulation, and hypoxia are activated and may differentially affect APD through remodeling of repolarizing atrial ion channels. Atrial APD is determined by the combined action of ionic currents. The role of small-conductance, calcium-activated K + (K Ca , SK) channels in atrial action potential repolarization has recently been delineated.<su -Abstract Truncated-

Downregulation of FKBP5 Promotes Atrial Arrhythmogenesis

TBX5 Mutations Contribute to Early-Onset Atrial Fibrillation in Chinese and Caucasians.

Cross-talk Between Macrophages and Atrial Myocytes in Atrial Fibrillation

KLF15 Loss-of-Function Mutation Underlying Atrial Fibrillation As Well As Ventricular Arrhythmias and Cardiomyopathy

FKBP12 is a critical regulator of the heart rhythm and the cardiac voltage-gated sodium current in mice

Fibroblast Growth Factor 21 Protects Against Atrial Remodeling Via Reducing Oxidative Stress.

Impaired Intracellular Calcium Buffering Contributes to the Arrhythmogenic Substrate in Atrial Myocytes From Patients With Atrial Fibrillation

Sensitized Signalling Between L-type Ca2+channels and Ryanodine Receptors in the Absence or Inhibition of FKBP12.6 in Cardiomyocytes

Genetic inhibition of nuclear factor of activated T-cell c2 prevents atrial fibrillation in CREM transgenic mice

Deciphering mechanisms of cardiomyocytes and non-cardiomyocyte transformation in myocardial remodeling of permanent atrial fibrillation

Cardiac-specific knockdown of Bhlhe40 attenuates angiotensin II (Ang II)-Induced atrial fibrillation in mice

Investigating the role of an orphan nuclear receptor NR4A1 in atrial fibrillation

Inward Rectifier K+ Currents Contribute to the Proarrhythmic Electrical Phenotype of Atria Overexpressing Cyclic Adenosine Monophosphate Response Element Modulator Isoform CREM-IbΔC-X

Atrial Myocyte NLRP3/CaMKII Nexus Forms a Substrate for Postoperative Atrial Fibrillation

Targeted inhibition of Focal Adhesion Kinase Attenuates Cardiac Fibrosis and Preserves Heart Function in Adverse Cardiac Remodeling

PPP1R12C Promotes Atrial Hypocontractility in Atrial Fibrillation

LIM Kinase 1 Acts As a Profibrotic Mediator in Permanent Atrial Fibrillation Patients with Valvular Heart Disease

Stress-Activated Kinase Mitogen-Activated Kinase Kinase-7 Governs Epigenetics of Cardiac Repolarization for Arrhythmia Prevention.

Trigger-Specific Remodeling of KCa2 Potassium Channels in Models of Atrial Fibrillation

Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation.

Decreased Left Atrial Cardiomyocyte FGF13 Expression Increases Vulnerability to Postoperative Atrial Fibrillation in Humans